Jana Chovancová

Statistics

Publications

Citations

131

H-Index

Active since

1997

Affiliations

Central European Institute of Technology – Masaryk University(Current)

Central European Institute of Technology

University Hospital Brno

Masaryk University

Slovak Academy of Sciences

Jana Chovancová is an author at Central European Institute of Technology – Masaryk University specializing in oncology, medicine, and cancer pharmacology.

ORCID

Publications per year

1997–2015

Publications

Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study

Michael Doubek, Yvona Brychtová, Anna Panovská et al. · American Journal of Hematology · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.

Juraj Bodo, Jana Chovancová, Ľuba Hunáková et al. · PubMed · 2005 · 20 citations

Medicine, Oncology, Pharmacology +17

Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8‐color flow cytometry protocol in routine hematological practice

Olga Stehlíková, Jana Chovancová, Boris Tichý et al. · International Journal of Laboratory Hematology · 2013 · 19 citations · Full text

Medicine, Hematology, Oncology +16

Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines.

Olga Sedlakova, J Sedlák, Ľuba Hunáková et al. · PubMed · 1999 · 17 citations

Medicine, Oncology, Pharmacology +9

Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.

Ľuba Hunáková, Juraj Bodo, Jana Chovancová et al. · PubMed · 2007 · 17 citations

Medicine, Cancer Biology, Oncology +12

1–5 of 8